Novel Neoadjuvant Immunotherapy Regimen Safety and Survival in Head and Neck Squamous Cell Cancer

Head and Neck - United States
doi 10.1002/hed.21660
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Squamous Cell Head and Neck Cancer

2005English

Combination Immunotherapy of Squamous Cell Carcinoma of the Head and Neck

Archives of Otolaryngology–Head & Neck Surgery
2000English

Nomograms Predicting Long-Term Overall Survival and Cancer-Specific Survival in Head and Neck Squamous Cell Carcinoma Patients

Oncotarget
Oncology
2016English

Co-Targeting EGFR and IKKβ/NF-κB Signalling Pathways in Head and Neck Squamous Cell Carcinoma: A Potential Novel Therapy for Head and Neck Squamous Cell Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Human Papilloma Virus in Head and Neck Squamous Cell Cancer.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Immunotherapy for Head and Neck Cancer

Anti-Cancer Drugs
Cancer ResearchOncologyPharmacology
2011English

Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma

Methods in Molecular Biology
GeneticsMolecular Biology
2009English

Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma: A Retrospective Evaluation in Latin America

Biomedical Journal of Scientific & Technical Research
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy